Robeco Institutional Asset Management B.V. Lowers Holdings in Humana Inc. (NYSE:HUM)

Robeco Institutional Asset Management B.V. decreased its holdings in Humana Inc. (NYSE:HUM - Free Report) by 52.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 92,449 shares of the insurance provider's stock after selling 100,323 shares during the period. Robeco Institutional Asset Management B.V. owned about 0.08% of Humana worth $42,324,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the company. Barlow Wealth Partners Inc. acquired a new position in shares of Humana during the fourth quarter valued at approximately $1,977,000. Auxano Advisors LLC acquired a new position in shares of Humana during the 4th quarter valued at about $540,000. Mariner LLC grew its holdings in shares of Humana by 2.3% in the third quarter. Mariner LLC now owns 14,119 shares of the insurance provider's stock valued at $6,869,000 after purchasing an additional 312 shares during the period. Massachusetts Financial Services Co. MA increased its position in Humana by 27.5% during the third quarter. Massachusetts Financial Services Co. MA now owns 27,943 shares of the insurance provider's stock worth $13,595,000 after purchasing an additional 6,034 shares during the last quarter. Finally, Silverarc Capital Management LLC purchased a new stake in Humana in the third quarter valued at $4,865,000. 92.38% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

HUM has been the subject of several research reports. Stephens dropped their target price on shares of Humana from $550.00 to $430.00 and set an "overweight" rating for the company in a report on Friday, January 26th. Bank of America reissued a "neutral" rating and issued a $342.00 price objective (down from $470.00) on shares of Humana in a research report on Tuesday, April 2nd. Barclays lowered their target price on shares of Humana from $356.00 to $310.00 and set an "equal weight" rating for the company in a research note on Tuesday, April 2nd. TD Cowen decreased their price objective on Humana from $427.00 to $396.00 and set a "buy" rating for the company in a report on Tuesday, April 2nd. Finally, Jefferies Financial Group decreased their price target on shares of Humana from $411.00 to $381.00 and set a "buy" rating for the company in a research note on Monday, April 22nd. Eleven research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $424.50.

Humana Stock Performance

HUM stock traded up $1.01 during mid-day trading on Friday, reaching $356.20. The company had a trading volume of 1,435,649 shares, compared to its average volume of 1,784,229. Humana Inc. has a one year low of $298.61 and a one year high of $530.54. The stock has a market capitalization of $42.92 billion, a P/E ratio of 22.15, a P/E/G ratio of 2.07 and a beta of 0.50. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.77. The stock's 50-day simple moving average is $322.15 and its two-hundred day simple moving average is $376.75.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.12 by $1.11. Humana had a return on equity of 17.76% and a net margin of 1.82%. The company had revenue of $29.61 billion for the quarter, compared to analysts' expectations of $28.52 billion. During the same period last year, the firm earned $9.38 EPS. The firm's revenue for the quarter was up 10.7% on a year-over-year basis. Research analysts anticipate that Humana Inc. will post 16.18 EPS for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, June 28th. This represents a $3.54 annualized dividend and a dividend yield of 0.99%. Humana's dividend payout ratio is 22.04%.

Insider Activity at Humana

In related news, Director Jorge S. Mesquita acquired 545 shares of the business's stock in a transaction that occurred on Tuesday, February 20th. The shares were acquired at an average cost of $367.09 per share, with a total value of $200,064.05. Following the purchase, the director now owns 2,578 shares of the company's stock, valued at $946,358.02. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.32% of the stock is currently owned by company insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.